Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with ...
Amazon S3 on MSN
Biomedical Intelligence at Scale with Lilly's AI Factory
Lilly is deploying biopharma’s most powerful AI Factory, built on the world’s first DGX B300 SuperPOD with over 1,000 ...
OpTek CTO Duane Dinke explains how laser processing optimizes optical fiber evanescence for next-gen biomedical diagnostics ...
Orchestra BioMed (Nasdaq:OBIO) today announced the first patient enrollments in a study of its Virtue Sirolimus AngioInfusion ...
Orchestra BioMed enrols first patients in Virtue SAB pivotal investigational device exemption coronary trial: New Hope, Pennsylvania Wednesday, October 29, 2025, 18:00 Hrs [IST] O ...
TipRanks on MSN
Orchestra BioMed Announces Strategic Agreement with Terumo
Orchestra BioMed Holdings ( ($OBIO) ) just unveiled an update. On October 28, 2025, Orchestra BioMed Holdings announced a new strategic agreement ...
New agreement grants Terumo Virtue SAB coronary indication right of first refusal and supersedes prior distribution agreementTerumo to pay a ...
Drug-releasing medical devices have revolutionized therapeutic delivery by integrating pharmacological function directly into biomedical implants. A ...
From ingestible pills that track gut health to smart bandages that can autonomously provide required treatment to wounds, ...
Orchestra BioMed (Nasdaq:OBIO) announced today that it entered into a termination and right of first refusal agreement with ...
Zanos, PhD, head of the Northwell's Division of Heath AI, and associate professor in the Feinstein Institutes' Institute of Bioelectronic Medicine and the Institute of Health System Science.
PhysioBiometrics, an affiliate of AGE-WELL network, has introduced Heel2Toe, a wearable device aimed at improving gait in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback